D. R. Knight, B. Elliott, B. J. Chang, T. T. Perkins, and T. V. Riley, Diversity and Evolution in the Genome of Clostridium difficile, Clin Microbiol Rev, vol.28, issue.3, pp.721-762, 2015.

D. W. Eyre, L. Tracey, B. Elliott, C. Slimings, P. G. Huntington et al., Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, Euro Surveill, vol.20, issue.10, p.21059, 2010.

K. Desai, S. B. Gupta, E. R. Dubberke, V. S. Prabhu, C. Browne et al., Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach, BMC Infect Dis, vol.16, p.303, 2016.

C. P. Kelly, Can we identify patients at high risk of recurrent Clostridium difficile infection?, Clin Microbiol Infect, vol.18, issue.6, pp.21-28, 2012.

D. N. Shah, S. L. Aitken, L. F. Barragan, S. Bozorgui, S. Goddu et al., Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study, J Hosp Infect, vol.93, issue.3, pp.286-295, 2016.

S. B. Debast, M. P. Bauer, and E. J. Kuijper, European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection, Clin Microbiol Infect, issue.2, pp.1-26, 1920.

E. Van-nood, A. Vrieze, M. Nieuwdorp, S. Fuentes, E. G. Zoetendal et al., Duodenal infusion of donor feces for recurrent Clostridium difficile, N Engl J Med, vol.368, issue.5, pp.407-422, 2013.

G. Cammarota, L. Masucci, G. Ianiro, S. Bibbò, G. Dinoi et al., Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, Aliment Pharmacol Ther, vol.41, issue.9, pp.835-878, 2015.

N. B. Henrikson and A. C. Skelly, Economic studies part I: basics and terms. Evid-Based Spine-Care J, vol.3, pp.7-11, 2012.

G. G. Konijeti, J. Sauk, M. G. Shrime, M. Gupta, and A. N. Ananthakrishnan, Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis, Clin Infect Dis, vol.58, issue.11, pp.1507-1521, 2014.

S. M. Bartsch, C. A. Umscheid, N. Fishman, and B. Y. Lee, Is fidaxomicin worth the cost? An economic analysis, Clin Infect Dis, vol.57, issue.4, pp.555-61, 2013.

P. M. Stranges, D. W. Hutton, and C. D. Collins, Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States, Value Health J Int Soc Pharmacoeconomics Outcomes Res, vol.16, issue.2, pp.297-304, 2013.

E. Mattila, R. Uusitalo-seppälä, M. Wuorela, L. Lehtola, H. Nurmi et al., Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology, vol.142, pp.490-496, 2012.

F. Rohlke, C. M. Surawicz, and N. Stollman, Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology, J Clin Gastroenterol, vol.44, issue.8, pp.567-70, 2010.

S. S. Yoon and L. J. Brandt, Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients, J Clin Gastroenterol, vol.44, issue.8, pp.562-568, 2010.

T. A. Rubin, C. E. Gessert, J. Aas, and J. S. Bakken, Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series, Anaerobe, vol.19, pp.22-28, 2013.

J. Aas, C. E. Gessert, and J. S. Bakken, Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube, Clin Infect Dis, vol.36, issue.5, pp.580-585, 2003.

Z. Kassam, R. Hundal, J. K. Marshall, and C. H. Lee, Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection, Arch Intern Med, vol.172, issue.2, pp.191-194, 2012.

M. S. Silverman, I. Davis, and D. R. Pillai, Success of self-administered home fecal transplantation for chronic Clostridium difficile infection, Clin Gastroenterol Hepatol, vol.8, issue.5, pp.471-474, 2010.

M. Tvede and J. Rask-madsen, Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients, Lancet Lond Engl, vol.1, issue.8648, pp.1156-60, 1989.

J. M. Wenisch, D. Schmid, H. Kuo, E. Simons, F. Allerberger et al., Hospital-acquired Clostridium difficile infection: determinants for severe disease, Eur J Clin Microbiol Infect Dis, vol.31, issue.8, pp.1923-1953, 2012.

K. Synnott, K. Mealy, C. Merry, L. Kyne, C. Keane et al., Timing of surgery for fulminating pseudomembranous colitis, Br J Surg, vol.85, issue.2, pp.229-260, 1998.

A. D. Perera, R. P. Akbari, M. S. Cowher, T. E. Read, J. T. Mccormick et al., Colectomy for fulminant Clostridium difficile colitis: predictors of mortality, Am Surg, vol.76, issue.4, pp.418-439, 2010.

J. C. Byrn, D. C. Maun, D. S. Gingold, D. T. Baril, J. J. Ozao et al., Predictors of mortality after colectomy for fulminant Clostridium difficile colitis, Arch Surg Chic Ill, vol.143, issue.2, pp.150-154, 1960.

. Asge-standards-of-practice-committee, D. A. Fisher, J. T. Maple, T. Ben-menachem, B. D. Cash et al., Complications of colonoscopy. Gastrointest Endosc, vol.74, issue.4, pp.745-52, 2011.

M. M. Olson, C. J. Shanholtzer, J. T. Lee, and D. N. Gerding, Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, vol.15, pp.371-81, 1982.

M. A. Miller, M. Hyland, M. Ofner-agostini, M. Gourdeau, and M. Ishak, Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance Program. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals, Infect Control Hosp Epidemiol, vol.23, issue.3, pp.137-177, 2002.

J. A. Karas, D. A. Enoch, and S. H. Aliyu, A review of mortality due to Clostridium difficile infection, J Infect, vol.61, issue.1, pp.1-8, 2010.

J. L. Hayes and P. Hansen, Is laparoscopic colectomy for cancer cost-effective relative to open colectomy?, ANZ J Surg, vol.77, issue.9, pp.782-788, 2007.

J. Vermeulen, M. P. Gosselink, J. Busschbach, and J. F. Lange, Avoiding or reversing Hartmann's procedure provides improved quality of life after perforated diverticulitis, J Gastrointest Surg, vol.14, issue.4, pp.651-658, 2010.

I. Youngster, J. Sauk, C. Pindar, R. G. Wilson, J. L. Kaplan et al., Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study, Clin Infect Dis, vol.58, issue.11, pp.1515-1537, 2014.

A. Link, T. Lachmund, C. Schulz, J. Weigt, and P. Malfertheiner, Endoscopic peroral jejunal fecal microbiota transplantation. Dig Liver Dis, 2016.

Z. Kassam, C. H. Lee, Y. Yuan, and R. H. Hunt, Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis, Am J Gastroenterol, vol.108, issue.4, pp.500-508, 2013.

, WHO Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development, 2001.

, Insee-Tableau-1.115-Produit intérieur brut et revenu national brut par habitant (Milliers de personnes, Milliards d'euros et Euros par personne

D. Husereau, M. Drummond, S. Petrou, C. Carswell, D. Moher et al., Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, Value Health J Int Soc Pharmacoeconomics Outcomes Res, vol.16, issue.2, pp.1-5, 2013.

M. Dodin and D. E. Katz, Faecal microbiota transplantation for Clostridium difficile infection, Int J Clin Pract, vol.68, issue.3, pp.363-371, 2014.

O. C. Aroniadis and L. J. Brandt, Intestinal Microbiota and the Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Disease, Gastroenterol Hepatol, vol.10, issue.4, pp.230-237, 2014.

G. W. Tannock, K. Munro, C. Taylor, B. Lawley, W. Young et al., A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiol Read Engl, vol.156, pp.3354-3363, 2010.

D. Bella, S. Gouliouris, T. Petrosillo, and N. , Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients, J Infect Chemother, vol.21, issue.4, pp.230-237, 2015.

C. R. Kelly, C. Ihunnah, M. Fischer, A. Khoruts, C. Surawicz et al., Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients, Am J Gastroenterol, vol.109, issue.7, pp.1065-71, 2014.

C. H. Lee, T. Steiner, E. O. Petrof, M. Smieja, D. Roscoe et al., Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial, JAMA, vol.315, issue.2, pp.142-151, 2016.